Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells

Research output: Contribution to journalShort survey

David H.M. Steffin, Helen Heslop

Original languageEnglish (US)
Pages (from-to)900-901
Number of pages2
JournalMolecular Therapy
Volume27
Issue number5
DOIs
StatePublished - May 8 2019

PMID: 31005599

Altmetrics

Cite this

Standard

Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells. / Steffin, David H.M.; Heslop, Helen.

In: Molecular Therapy, Vol. 27, No. 5, 08.05.2019, p. 900-901.

Research output: Contribution to journalShort survey

Harvard

Steffin, DHM & Heslop, H 2019, 'Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells' Molecular Therapy, vol. 27, no. 5, pp. 900-901. https://doi.org/10.1016/j.ymthe.2019.04.007

APA

Steffin, D. H. M., & Heslop, H. (2019). Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells. Molecular Therapy, 27(5), 900-901. https://doi.org/10.1016/j.ymthe.2019.04.007

Vancouver

Steffin DHM, Heslop H. Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells. Molecular Therapy. 2019 May 8;27(5):900-901. https://doi.org/10.1016/j.ymthe.2019.04.007

Author

Steffin, David H.M. ; Heslop, Helen. / Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells. In: Molecular Therapy. 2019 ; Vol. 27, No. 5. pp. 900-901.

BibTeX

@article{d1763d19c5e84f0f9a945c05b80343a6,
title = "Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells",
author = "Steffin, {David H.M.} and Helen Heslop",
year = "2019",
month = "5",
day = "8",
doi = "10.1016/j.ymthe.2019.04.007",
language = "English (US)",
volume = "27",
pages = "900--901",
journal = "Molecular therapy : the journal of the American Society of Gene Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "5",

}

RIS

TY - JOUR

T1 - Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells

AU - Steffin, David H.M.

AU - Heslop, Helen

PY - 2019/5/8

Y1 - 2019/5/8

UR - http://www.scopus.com/inward/record.url?scp=85064323156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064323156&partnerID=8YFLogxK

U2 - 10.1016/j.ymthe.2019.04.007

DO - 10.1016/j.ymthe.2019.04.007

M3 - Short survey

VL - 27

SP - 900

EP - 901

JO - Molecular therapy : the journal of the American Society of Gene Therapy

T2 - Molecular therapy : the journal of the American Society of Gene Therapy

JF - Molecular therapy : the journal of the American Society of Gene Therapy

SN - 1525-0016

IS - 5

ER -

Similar Experts

Similar Research Outputs Profiled Experts

Similar research outputs

Similar Research Outputs

  1. Histone modifications are associated with 9-tetrahydrocannabinol-mediated alterations in antigenspecific t cell responses

    Yang, X., Hegde, V. L., Rao, R., Zhang, J., Nagarkatti, P. S. & Nagarkatti, M., Jul 4 2014, In : Journal of Biological Chemistry. 289, 27, p. 18707-18718 12 p.

    Research output: Contribution to journalArticle

  2. Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4

    Cruz, C. R., Gerdemann, U., Leen, A. M., Shafer, J. A., Ku, S., Tzou, B., Horton, T. M., Sheehan, A., Copeland, A., Younes, A., Rooney, C. M., Heslop, H. & Bollard, C. M., Nov 15 2011, In : Clinical Cancer Research. 17, 22, p. 7058-7066 9 p.

    Research output: Contribution to journalArticle

  3. Adoptive Immunotherapy with Antigen-Specific T Cells Expressing a Native TCR

    Leung, W. & Heslop, H., Apr 1 2019, In : Cancer immunology research. 7, 4, p. 528-533 6 p.

    Research output: Contribution to journalReview article

  4. Kinetics of tumor destruction by chimeric antigen receptor-modified T cells

    Anurathapan, U., Chan, R. C., Hindi, H. F., Mucharla, R., Bajgain, P., Hayes, B. C., Fisher, W. E., Heslop, H., Rooney, C. M., Brenner, M., Leen, A. M. & Vera, J. F., Jan 1 2014, In : Molecular Therapy. 22, 3, p. 623-633 11 p.

    Research output: Contribution to journalArticle

ID: 47990178